by Jon Rappoport
January 26, 2020
The US National Institutes of Health (NIH) is launching a rush program to develop a vaccine against the China coronavirus.
The goal? Have a vaccine ready for human testing in an unprecedented 90 days.
NIH is partnering with a US vaccine company, Moderna, Inc.
The vaccine is a new type called RNA. According to Reuters (“With Wuhan virus genetic code in hand, scientists begin work on a vaccine,” Jan 24, 2020), “[these are] vaccines based on ribonucleic acid (RNA)—a chemical messenger that contains instructions for making proteins.”
The PHG Foundation/University of Cambridge explains further: “Unlike a normal vaccine, RNA vaccines work by introducing an mRNA sequence (the molecule which tells cells what to build) which is coded for a disease specific antigen [virus]; once produced within the body, the antigen [virus] is recognised by the immune system, preparing it to fight the real thing.”
Let’s have a look at Moderna (twitter), the company that will be making and testing the new RNA vaccine against the China coronavirus. Its website states, in a January 23rd press release: “Moderna Announces Funding Award from CEPI to Accelerate Development of Messenger RNA (mRNA) Vaccine Against Novel Coronavirus”.
Funded by CEPI. Who is that? (twitter) Its website states: “CEPI is a innovative global partnership between public, private, philanthropic, and civil society organisations. We’re working together to accelerate the development of vaccines against emerging infectious diseases and enable equitable access to these vaccines for people during outbreaks.”
A more relevant quote: “CEPI was founded in Davos by the governments of Norway and India, the Bill & Melinda Gates Foundation, the Wellcome Trust, and the World Economic Forum.”
Bill Gates. Doesn’t that send your trust and faith rocketing up into the sky?